4.4 Article

Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium

期刊

DEVELOPMENTAL DYNAMICS
卷 235, 期 1, 页码 50-59

出版社

WILEY
DOI: 10.1002/dvdy.20593

关键词

chick; embryo; coronary vessel; transforming growth factor-beta

资金

  1. NHLBI NIH HHS [P01 HL067105, R01 HL052922-10, R01 HL052922, HL076133, HL52922, HL067105, T32 HL076133, P01 HL067105-05] Funding Source: Medline
  2. NIGMS NIH HHS [GM007628, T32 GM007628] Funding Source: Medline
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076133, R01HL052922, P01HL067105] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The proepicardium (PE) migrates over the heart and forms the epicardium. A subset of these PE-derived cells undergoes epithelial-mesenchymal transformation (EMT) and gives rise to cardiac fibroblasts and components of the coronary vasculature. We report that transforming growth factor-beta (TGF beta) I and TGF beta 2 increase EMT in PE explants as measured by invasion into a collagen gel, loss of cytokeratin expression, and redistribution of ZO1. The type I TGF beta receptors ALK2 and ALK5 are both expressed in the PE. However, only constitutively active (ca) ALK2 stimulates PE-derived epithelial cell activation, the first step in transformation, whereas caALK5 stimulates neither activation nor transformation in PE explants. Overexpression of Smad6, an inhibitor of ALK2 signaling, inhibits epithelial cell activation, whereas BMP7, a known ligand for ALK2, has no effect. These data demonstrate that TGF beta stimulates transformation in the PE and suggest that ALK2 partially mediates this effect.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据